|Videos|December 14, 2022

Interview with Syngene at CPHI in Frankfurt, Germany

Author(s)Syngene

KEY LEARNING OBJECTIVES

  • Syngene is an end-to-end CRO/CDMO which offers standalone as well as integrated services for small molecules and biologics
  • We not only have capabilities but also capacity to fulfil commercial manufacturing requirements
  • We can be a innovation partner for niche areas as well as small biotech/pharma companies

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content